What RTI Health Solutions does

RTI Health Solutions is a privately held life science consulting organization affiliated with RTI International, operating from its headquarters in Durham, North Carolina (Research Triangle Park) with additional offices in Barcelona (Spain), Ljungskile (Sweden), Lyon (France), and Manchester (United Kingdom). The firm sells professional services to pharmaceutical, bioscience, and healthcare payer/regulator clients, generating evidence to support regulatory submissions, health technology assessments, reimbursement decisions, and market access across the product lifecycle. Its work is grounded in health economics and outcomes research (HEOR), epidemiology, biostatistics, patient-centered research, and real-world evidence generation, supported by academically trained researchers with PhDs and master's degrees from institutions such as UNC Chapel Hill, Duke, and the University of Rochester.

The firm's service portfolio is organized into four service categories—Value, Access, and HEOR; Patient-Centered Research; Regulatory and Safety; and Medical Communications—and four strategic solutions: Real-World Evidence, Medical Affairs, Joint Clinical Assessment (JCA), and Implementation Science. Specific offerings include HTA submissions, global value dossiers, PICO prediction for the EU JCA process, patient-reported outcomes, postauthorization safety studies, and medical writing/publication strategy. Distribution is sales-led and direct to enterprise pharma clients, supported by conference presence at ISPOR and DIA RWE, a webinar and resource center, and active LinkedIn/YouTube/Bluesky channels.

Revenue is generated on a project-by-project professional services basis with no publicly disclosed pricing, deal sizes, or financial performance. The firm employs 251-500 staff and is positioned as a globally recognized research organization, though revenue, headcount growth, and ownership structure beyond its nonprofit parent affiliation are not disclosed. A November 2025 three-way partnership with BEKhealth and Innovo Research marks its most recent disclosed strategic move, extending its real-world evidence capabilities through a third-party AI platform and a multi-state clinical practice network.

Name

RTI Health Solutions

Legal name

RTI Health Solutions

Website

https://rtihs.org

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

251–500 employees

Short description

RTI Health Solutions is a private, globally recognized life science consulting firm that provides health economics, outcomes research, regulatory, real-world evidence, and medical communications services to pharmaceutical and bioscience companies across the US and Europe.

Ownership category

akta.pro rank

Product category

Life Science Consulting

NAICS

Other Scientific and Technical Consulting Services (541690), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

Keywords

• Health economics outcomes research
• Real-world evidence
• Regulatory strategy consulting
• Patient-centered research
• Medical communications

Headquarters

HQ city

Parsippany

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Life Science Consulting Services: Professional consulting services including health economics, outcomes research, regulatory strategy, epidemiology, biostatistics, patient-centered research, real-world evidence generation, medical communications, and strategic advisory services for pharmaceutical and bioscience companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

RTI Health Solutions provides life science consulting services to pharmaceutical and bioscience companies, offering health economics and outcomes research (HEOR), patient-centered research, regulatory and safety services, medical communications, real-world evidence generation, and strategic solutions including EU Joint Clinical Assessment and implementation science throughout the product lifecycle.

Product overview

RTI Health Solutions is a globally recognized research organization offering life science consulting services through a multi-category portfolio. The company provides a comprehensive suite of services organized into four main Service Categories (Value, Access, and HEOR; Patient-Centered Research; Regulatory and Safety; Medical Communications) and four Strategic Solutions (Real-World Evidence; Medical Affairs; Joint Clinical Assessment; Implementation Science). Key offerings include Integrated Evidence Strategy, Expert Insights, Medical Education, PICO Prediction Services, Joint Scientific Consultation, Global Value Dossiers, and HTA Submissions. The company supports pharmaceutical and bioscience companies throughout the product lifecycle with evidence generation, strategy, and communication services.

Differentiator

Problem solved

Functional benefit

Products and services

• Value, Access, and HEOR Service category that demonstrates value, optimizes access strategies, and supports evidence-based decision-making through Health Economics, Value and Access, HTA and Reimbursement Submissions, and Outcomes Research for pharmaceutical and bioscience companies.
• Patient-Centered Research Service category that ensures therapies reflect real needs of patients, improve outcomes, and support value-based care through Patient-Reported Outcomes and Health Preference Assessment.
• Regulatory and Safety Service category to inform safe, effective drug development and meet regulatory demands across global markets through Epidemiology, Biostatistics, and Regulatory Strategy and Support.
• Medical Communications Service category to improve patient outcomes with publication strategies that increase knowledge and understanding through Integrated Evidence Strategy, Expert Insights, Medical Writing and Publication Strategy, and Creative and Digital Solutions.
• Real-World Evidence Strategic solution that incorporates real-world evidence at every stage of drug or device development journey through Regulatory RWE Strategy, Database and Registry Research, RWE with Primary Data Collection, and Research Collaborations.
• Medical Affairs Strategic solution to solve key challenges in medical affairs with a cross-functionally aligned scientific strategy, supporting product lifecycle and launch excellence through Integrated Evidence Strategy, Expert Insights, and Medical Education.
• Joint Clinical Assessment (JCA) Strategic solution to prepare for and navigate the EU JCA process with strategic and technical services including JCA Strategy and Planning, PICO Prediction, Joint Scientific Consultation, and JCA Evidence Generation and Synthesis.
• Implementation Science Strategic solution that bridges the gap between clinical development and practical application to ensure innovations reach patients.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Partnerships

Two partnerships are on record, tiered core.

• BEKhealthcoreStrategic or Co-development Partner · 4 November 2025BEKhealth has expanded its partnership with Innovo Research and RTI Health Solutions to enhance the collection and use of real-world data in healthcare and clinical research. The collaboration involves utilizing BEKhealth's AI platform with Innovo's network of health practices across eight states, targeting improved patient outcomes and data-driven decision making.
• Innovo ResearchcoreStrategic or Co-development Partner · 4 November 2025Innovo Research partners with BEKhealth and RTI Health Solutions in a three-way collaboration to enhance real-world data collection and use. Innovo provides its network of health practices across eight states to support improved patient outcomes through data-driven decision making in healthcare and clinical research.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• Evidera: Evidera is a dedicated HEOR, RWE, market access and patient-centered research consulting firm serving the same pharmaceutical and bioscience clients as RTI Health Solutions. Acquired by PPD (now part of Thermo Fisher), it is one of the closest direct comparables in scale and service mix.
• Cytel: Cytel provides biostatistics, HEOR, RWE and clinical development analytics consulting to pharma. It is a direct peer in methodologies (biostatistics, real-world evidence) and in client base overlap with RTI's epidemiology, biostatistics and RWE practices.
• Analysis Group: Analysis Group is a private economics and strategy consulting firm with a sizeable health economics, outcomes research and epidemiology practice serving pharma and biotech. It directly competes with RTI on HEOR and patient-centered research engagements.
• Trinity Life Sciences: Trinity Life Sciences offers commercial strategy, HEOR, RWE and medical affairs consulting to pharma and biotech. It is a direct peer in the market access, RWE and medical communications spaces where RTI Health Solutions also competes.
• Wickenstones: Wickenstones is a specialist HEOR, market access and value communications consultancy serving pharmaceutical clients. It competes with RTI on HTA submissions, value dossiers and HEOR evidence generation projects.
• Charles River Associates: CRA's Life Sciences practice provides HEOR, epidemiology, biostatistics and strategic consulting to pharma and medical device clients. It is a direct competitor in the same quantitative evidence-generation services that anchor RTI's practice.
• Putnam Associates: Putnam Associates is a life sciences strategy consulting firm with deep practices in market access, pricing, HEOR and real-world evidence. It competes directly with RTI on market access and value demonstration engagements for pharma sponsors.

Broad incumbents

• IQVIA: IQVIA is the largest life sciences services platform, offering clinical, HEOR, RWE and market access capabilities alongside its technology offerings. It is a broad incumbent that competes with RTI on HEOR engagements while also serving as a buyer of specialized HEOR firms.
• ICON plc: ICON (post-PRA Health Sciences merger) is a top-tier global CRO offering HEOR, real-world evidence, market access and patient-reported outcomes services. It competes with RTI Health Solutions on commercial-stage evidence work as part of an integrated clinical-plus-commercial bundle.
• Parexel International: Parexel is a global clinical CRO with substantial HEOR, RWE, regulatory strategy and market access consulting practices. It competes with RTI particularly on pharma-sponsored evidence generation and HTA support engagements.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/RTIHS
• YouTubeyoutube.com/channel/UCN4ZJF7bIcFgAZgHvpazF9g
• LinkedInlinkedin.com/company/rti-health-solutions

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RTI Health Solutions